Kim Wiegertjes1
Sabine Voigt2Wilmar M. T. Jolink3Emma A. Koemans2
Floris H. B. M. Schreuder1
Marianne A. A. van Walderveen3
Marieke J. H. Wermer4
Frederick J. A. Meijer5Marco Duering6Frank-Erik de Leeuw1
Catharina J. M. Klijn1*- 1Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, Netherlands
- 2Department of Neurology, Leiden University Medical Center, Leiden, Netherlands
- 3Department of Radiology, Leiden University Medical Center, Leiden, Netherlands
- 4Department of Neurology and Neurosurgery, University Medical Center Utrecht, Brain Center, Utrecht University, Utrecht, Netherlands
- 5Department of Medical Imaging, Radboud University Medical Center, Nijmegen, Netherlands
- 6Department of Biomedical Engineering, Medical Image Analysis Center (MIAC AG) and qbig, University of Basel, Basel, Switzerland
The current study aimed to investigate whether diffusion-weighted imaging-positive (DWI+) lesions after acute intracerebral hemorrhage (ICH) are associated with underlying small vessel disease (SVD) or linked to the acute ICH. We included patients ≥18 years with spontaneous ICH confirmed on neuroimaging and performed 3T MRIs after a median of 11 days (interquartile range [IQR] 6–43). DWI+ lesions were assessed in relation to the hematoma (perihematomal vs. distant and ipsilateral vs. contralateral). Differences in clinical characteristics, ICH characteristics, and MRI markers of SVD between participants with or without DWI+ lesions were investigated using non-parametric tests. We observed 54 DWI+ lesions in 30 (22%) of the 138 patients (median age [IQR] 65 [55–73] years; 71% men, 59 lobar ICH) with available DWI images. We found DWI+ lesions ipsilateral (54%) and contralateral (46%) to the ICH, and 5 (9%) DWI+ lesions were located in the immediate perihematomal region. DWI+ lesion presence was associated with probable CAA diagnosis (38 vs. 15%, p = 0.01) and larger ICH volumes (37 [8–47] vs. 12 [6–24] ml, p = 0.01), but not with imaging features of SVD. Our findings suggest that DWI+ lesions after ICH are a feature of both the underlying SVD and ICH-related mechanisms.
Introduction
In patients with acute intracerebral hemorrhage (ICH) due to small vessel disease (SVD), diffusion-weighted imaging-positive (DWI+) lesions occur on average in 20% on MRI performed within 90 days (1). These DWI+ lesions have been associated with worse outcomes (2). Although DWI+ lesions are less frequent in patients with SVD without ICH (<5%) (3), it remains uncertain whether this high frequency of DWI+ lesions is secondary to the acute ICH or the result of the underlying SVD.
Recent meta-analyses on individual patient data demonstrated the association between DWI+ lesions after ICH with both magnetic resonance (MRI) markers of cerebral SVD and ICH characteristics, but data on the timing and location of DWI+ lesions in relation to the ICH were not available (1, 2). Therefore, we aimed to investigate the prevalence, timing, and location of DWI+ lesions in survivors of SVD-related ICH.
Materials and Methods
Detailed methods are available in the online data supplement.
Study Design and Population
A total of 204 patients presenting to the University Medical Centers of Nijmegen, Utrecht, or Leiden, with a symptomatic spontaneous ICH, confirmed on CT were included in the multi-center prospective cohort Finding the ETiology in spontaneous Cerebral Hemorrhage (FETCH) study between October 2013 and December 2018, of whom 155 underwent 3T MRI (4). Secondary causes of ICH were excluded by CT angiography, MRI/magnetic resonance angiography, or angiogram. There were minor differences in patient demographics and ICH characteristics on brain CT between the 155 participants who underwent MRI and 49 participants without MRI (Supplementary Table S1). Of all participants who had MRI, 17 participants were excluded due to inadequate DWI image quality. This resulted in a final sample size of 138 participants (median [IQR] age 65 [55–73] years; 98 men [71%]) with a median interval between the qualifying ICH and MRI of 11 days (IQR 6–43). In total, 112 patients underwent MRI in the acute phase (<7 days) and 26 in the non-acute phase (≥7 days). This study was approved by the Medical Ethics Review Committee of the University Medical Center Utrecht. Patients provided written informed consent.
Neuroimaging Markers
Participants underwent 3T MRIs within 3 months of ICH onset using a standardized MRI protocol (Supplementary Table S2).
We classified the location of the ICH as lobar (cerebral lobes) or non-lobar (thalamus, basal ganglia, brainstem, or cerebellum) (5). We assessed ICH volume and perihematomal edema volume on FLAIR with manual segmentation using ITK-SNAP 3.8 (http://www.itksnap.org/). Subsequently, we calculated the edema extension distance (EED), as this measure is relatively independent of ICH volume (6). The following MRI markers of SVD were rated according to the STandards for ReportIng Vascular ChangEs on neuroimaging (STRIVE) criteria (7), using validated scales: white matter hyperintensities (WMH); lacunes; cerebral microbleeds (CMB); (8) any cortical superficial siderosis (focal and disseminated); (9) the probability of cerebral amyloid angiopathy according to the Modified Boston criteria (9).
Diffusion-weighted imaging-positive lesions were defined as hyperintense lesions ≤ 20 mm on diffusion-weighted imaging and a hypointense or isointense signal on apparent diffusion coefficient maps at the corresponding location and assessed by one trained rater (SV) (7). A second rater (EAK) assessed DWI+ lesion presence in a random subsample indicating perfect agreement (n = 10%, Cohen's kappa 1.00 [95% CI = 1–1]). The location of DWI+ lesions in relation to the ICH was assessed as follows: (1) perihematomal (<10 mm of the hematoma); (2) ipsilateral or contralateral; (3) supratentorial or infratentorial. DWI images and corresponding lesion masks were registered to the native T1-weighted images and subsequently normalized into MNI-152 standard space. Lesion coordinates were extracted from the co-registered lesion masks and visualized using BrainNet Viewer (http://www.nitrc.org/projects/nmv/) to investigate whether ipsilateral and contralateral DWI+ lesions have a similar distribution throughout the brain, which would be indicative of a more widespread cause than the acute ICH alone.
Diffusion-weighted data sets were pre-processed and diffusion tensors were estimated as described in detail in the online-only Data Supplement.
Statistical Analysis
Statistical analyses were performed in R (R Foundation). Comparisons of DWI+ lesion prevalence between individuals with acute ( ≤ 7 days) vs. non-acute (>7 days) MRI scans and differences between individuals with or without any DWI+ lesions were performed using Mann-Whitney U tests and χ2 tests (or Fisher exact tests when appropriate). A two-tailed α was set at 0.05.
Results
Among the 138 patients, 98 were men [71%], and their median age was 65 years (interquartile range [IQR] 55–73). In 59 of 138 patients, the ICH was lobar (43%), and in 79 (57%) non-lobar (56 deep and 23 infratentorial). Among the 59 patients, 24 (41%) with lobar ICH fulfilled the modified Boston criteria for probable CAA. Finally, 53 of the 138 patients had MRIs within 7 days.
We identified 54 DWI+ lesions in 30 of the 138 patients (22%), of which 5 (9%) were located in perihematomal regions. DWI+ lesions were equally distributed in both hemispheres (ipsilateral 54% and contralateral 46%; Figure 1). Furthermore, supratentorial DWI+ lesions were not more frequent in patients with infratentorial ICH compared to patients with supratentorial ICH (26 vs. 20%, p = 0.50). There were more patients with probable CAA in the DWI+ group compared to the DWI- group (38 vs. 15%, p = 0.01). Individuals with probable CAA more often had strictly cortical DWI+ lesions than individuals with no-CAA ICH (78 vs. 17%, p < 0.01).
Figure 1. Topographical distribution of DWI+ lesions. DWI+, diffusion-weighted imaging-positive.
We observed DWI+ lesions on MRIs up to 86 days after the ICH (Figure 2). The frequency of DWI+ lesions appeared similar on acute and non-acute MRI scans. In total, 12 of the patients with recent ICH had DWI+ lesions (23%) compared to 18 of the individuals with non-recent MRI (21%, p = 0.90).
Figure 2. Histogram of the number of DWI+ lesions and time between MRI and ICH. DWI+, diffusion-weighted imaging-positive. MRI, magnetic resonance imaging; ICH, intracerebral hemorrhage.
Although we found larger ICH volumes in patients with DWI+ lesions relative to those without (37 [8–47] vs. 12 [6–24] ml, p = 0.01), clinical characteristics and SVD imaging features were similar between groups (Table 1).
Table 1. Characteristics of participants with and without DWI+ lesions.
Discussion
Our results demonstrate a widespread distribution of DWI+ lesions after spontaneous ICH, unrelated to the anatomical location of the hematoma and unrelated to the time after ICH onset. DWI+ lesion presence was associated with ICH volume and a diagnosis of probable CAA, but not with all imaging features of SVD.
The similar distribution of ipsilateral and contralateral DWI+ lesions, and their high frequency outside the acute post-ICH period, suggest that these lesions are reflections of the underlying SVD. The absence of a statistically significant association between DWI+ lesions and SVD markers (other than those indicating CAA) could be due to the small sample size. The finding that DWI+ lesions were more frequent in cases diagnosed with probable CAA, especially in cortical regions, may indicate that the accumulation of amyloid-β in the vessel walls of cortical and leptomeningeal vessels could be related to the formation of abnormal blood clots resistant to degradation, as demonstrated in recent in vitro and in vivo studies (10). Future studies should investigate whether (cortical) DWI+ lesions are different between CAA vs. non-CAA patients and whether they have distinct underlying pathophysiological mechanisms.
Global mechanisms secondary to the ICH, such as immune-mediated mechanisms or blood-brain barrier breakdown, could also be involved in the origin of ICH-related DWI+ lesions (11), since patients with DWI+ lesions had considerably larger ICH volumes. Although beyond the scope of the current study, hypertension and its treatment in the acute phase may have influenced the occurrence of DWI+ lesions (12). However, the number of patients with hypertension did not differ between groups with and without DWI+ lesions. Furthermore, a recent individual patient data meta-analyses investigated ICH-related DWI+ lesions, blood pressure control, and outcomes, and did not find any associations (2), and a recent randomized controlled trial demonstrated that intensive acute blood pressure lowering did not lower the frequency of DWI+ lesions in ICH-patients (13), Alternatively, some hemorrhages might be caused by the hemorrhagic transformation of DWI+ lesions (14, 15).
Whereas, CAA is a major risk factor for recurrent ICH, this study suggests that CAA also predisposes to a higher DWI+ lesion frequency. This poses a clinical dilemma regarding the risk of future hemorrhagic or ischemic events when treating patients with acute ICH, including the use or avoidance of antithrombotic therapy or aggressive blood pressure lowering (16, 17), which should be addressed in future randomized controlled clinical trials.
The main strength of our study includes the unique cohort of ICH patients who underwent MRI during the acute or subacute phase of ICH. However, not all patients underwent MRI, in particular those who were in poor clinical condition, causing selection bias. Limitations of our study are the small sample size preventing us from multivariable regression analysis adjusted for several confounders, and the use of different scanners, although with aligned protocols.
These findings suggest that ICH-related DWI+ lesions are an ongoing process associated with the underlying SVD and are possibly promoted by the acute event of the ICH.
Data Availability Statement
Data request can be sent to the corresponding author (karin.klijn@radboudumc.nl).
Ethics Statement
The studies involving human participants were reviewed and approved by Medical Ethics Review Committee of the University Medical Center Utrecht. The patients/participants provided their written informed consent to participate in this study.
Author Contributions
KW performed the statistical analysis, data interpretation, and drafting and revision of the manuscript. SV, WJ, EK, and FM participated in data acquisition and revised the manuscript for intellectual content. MWa, MWe, and FM contributed to the study concept and design and revised the manuscript for intellectual content. MD contributed to data interpretation and revised the manuscript for intellectual content. F-EL contributed to data interpretation and drafting and revision of the manuscript. CK contributed to the study design and concept, data acquisition and interpretation, and drafting and revision of the manuscript. All authors contributed to the article and approved the submitted version.
Funding
MWe was supported by a personal ZonMw VIDI grant (91717337), the Netherlands Heart Foundation (2016T086), and the Dutch CAA Foundation. MD was supported by the German Research Foundation (DU1626/1–1). FS was supported by the Dutch Heart Foundation (Grant No. 2019T060). FS and CK were supported by a clinically established investigator grant from the Dutch Heart Foundation (Grant No. 2012 T077). CK was supported by an Aspasia grant from The Netherlands Organization for Health Research and Development (ZonMw Grant No. 015.008.048). F-ED was supported by a clinically established investigator grant of the Dutch Heart Foundation (Grant No. 2014 T060) and by a VIDI innovational grant from the Netherlands Organization for Health Research and Development (ZonMw Grant No. 016.126.351).
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary Material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fneur.2022.882070/full#supplementary-material
References
1. Boulanger M, Schneckenburger R, Join-Lambert C, Werring DJ, Wilson D, Hodel J, et al. Diffusion-weighted imaging hyperintensities in subtypes of acute intracerebral hemorrhage. Stroke. (2019) 50:135–42. doi: 10.1161/STROKEAHA.118.021407
2. Murthy SB, Cho SM, Gupta A, Shoamanesh A, Navi BB, Avadhani R, et al. A pooled analysis of diffusion-weighted imaging lesions in patients with acute intracerebral hemorrhage. JAMA Neurol. (2020) 77:1390–7. doi: 10.1001/jamaneurol.2020.2349
3. Wiegertjes K, Ter Telgte A, Oliveira PB, van Leijsen EMC, Bergkamp MI, van Uden IWM, et al. The role of small diffusion-weighted imaging lesions in cerebral small vessel disease. Neurology. (2019) 93:e1627–34. doi: 10.1212/WNL.0000000000008364
4. Jolink WM, Lindenholz A, van Etten ES, van Nieuwenhuizen KM, Schreuder FH, Kuijf HJ, et al. Contrast leakage distant from the hematoma in patients with spontaneous ICH: a 7 T MRI study. J Cereb Blood Flow Metab. (2020) 40:1002–11. doi: 10.1177/0271678X19852876
5. Charidimou A, Schmitt A, Wilson D, Yakushiji Y, Gregoire SM, Fox Z, et al. The Cerebral Haemorrhage Anatomical RaTing inStrument (CHARTS): development and assessment of reliability. J Neurol Sci. (2017) 372:178–83. doi: 10.1016/j.jns.2016.11.021
6. Parry-Jones AR, Wang X, Sato S, Mould WA, Vail A, Anderson CS, et al. Edema extension distance: outcome measure for Phase II clinical trials targeting edema after intracerebral hemorrhage. Stroke. (2015) 46:e137–40. doi: 10.1161/STROKEAHA.115.008818
7. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. (2013) 12:822–38. doi: 10.1016/S1474-4422(13)70124-8
8. Gregoire SM, Chaudhary UJ, Brown MM, Yousry TA, Kallis C, Jager HR, et al. The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds. Neurology. (2009) 73:1759–66. doi: 10.1212/WNL.0b013e3181c34a7d
9. Linn J, Halpin A, Demaerel P, Ruhland J, Giese AD, Dichgans M, et al. Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology. (2010) 74:1346–50. doi: 10.1212/WNL.0b013e3181dad605
10. Cortes-Canteli M, Paul J, Norris EH, Bronstein R, Ahn HJ, Zamolodchikov D, et al. Fibrinogen and beta-Amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease. Neuron. (2010) 66:695–709. doi: 10.1016/j.neuron.2010.05.014
11. Xu XH, Gao T, Zhang WJ, Tong LS, Gao F. Remote diffusion-weighted imaging lesions in intracerebral hemorrhage: characteristics, mechanisms, outcomes, and therapeutic implications. Front Neurol. (2017) 8:678. doi: 10.3389/fneur.2017.00678
12. Kidwell CS, Rosand J, Norato G, Dixon S, Worrall BB, James ML, et al. Ischemic lesions, blood pressure dysregulation, and poor outcomes in intracerebral hemorrhage. Neurology. (2017) 88:782–8. doi: 10.1212/WNL.0000000000003630
13. Shoamanesh A, Cassarly C, Morotti A, Romero JM, Oliveira-Filho J, Schlunk F, et al. Intensive blood pressure lowering and DWI lesions in intracerebral hemorrhage: exploratory analysis of the ATACH-2 randomized trial. Neurocrit Care. (2022) 36:71–81. doi: 10.1007/s12028-021-01254-9
14. van Veluw SJ, Lauer A, Charidimou A, Bounemia N, Xiong L, Boulouis G, et al. Evolution of DWI lesions in cerebral amyloid angiopathy: evidence for ischemia. Neurology. (2017) 89:2136–42. doi: 10.1212/WNL.0000000000004668
15. Ter Telgte A, Wiegertjes K, Gesierich B, Marques JP, Huebner M, de Klerk JJ, et al. Contribution of acute infarcts to cerebral small vessel disease progression. Ann Neurol. (2019) 86:582–92. doi: 10.1002/ana.25556
16. Auriel E, Gurol ME, Ayres A, Dumas AP, Schwab KM, Vashkevich A, et al. Characteristic distributions of intracerebral hemorrhage-associated diffusion-weighted lesions. Neurology. (2012) 79:2335–41. doi: 10.1212/WNL.0b013e318278b66f
Keywords: diffusion-weighted imaging, intracerebral hemorrhage, small vessel disease, magnetic resonance imaging, cerebral amyloid angiopathy
Citation: Wiegertjes K, Voigt S, Jolink WMT, Koemans EA, Schreuder FHBM, van Walderveen MAA, Wermer MJH, Meijer FJA, Duering M, de Leeuw F-E and Klijn CJM (2022) Diffusion-Weighted Lesions After Intracerebral Hemorrhage: Associated MRI Findings. Front. Neurol. 13:882070. doi: 10.3389/fneur.2022.882070
Received: 23 February 2022; Accepted: 02 May 2022;
Published: 15 June 2022.
Edited by:
Marco Pasi, Centre Hospitalier Universitaire de Tours, FranceReviewed by:
Carlos Kase, Boston University, United StatesAlessandro Biffi, Massachusetts General Hospital and Harvard Medical School, United States
Copyright © 2022 Wiegertjes, Voigt, Jolink, Koemans, Schreuder, van Walderveen, Wermer, Meijer, Duering, de Leeuw and Klijn. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Catharina J. M. Klijn, karin.klijn@radboudumc.nl